Lung function in never smoking patients with alpha1antitrypsin deficiency

R. A. Stockley, R. G. Edgar (Birmingham, United Kingdom)

Source: Annual Congress 2013 –Lung function tests to monitor airway diseases
Session: Lung function tests to monitor airway diseases
Session type: Poster Discussion
Number: 4709
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
R. A. Stockley, R. G. Edgar (Birmingham, United Kingdom). Lung function in never smoking patients with alpha1antitrypsin deficiency. Eur Respir J 2013; 42: Suppl. 57, 4709

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Air trapping is associated with exercise capacity in persons without overt obstructive lung disease
Source: International Congress 2016 – Mechanisms of symptoms and exercise limitation in health and disease
Year: 2016


Small airway obstruction involvement in COPD severity
Source: Annual Congress 2013 –Diagnosis and management of respiratory diseases
Year: 2013


Proteinase-inhibitor system state in patients with COPD
Source: International Congress 2015 – COPD: chronic disease and comorbidities
Year: 2015

Antagonism of substance P and perception of dyspnea in patients with COPD
Source: Annual Congress 2013 –COPD mechanisms
Year: 2013

Plasma surfactant protein D (SP-D) and smoking status in patients with COPD
Source: International Congress 2014 – COPD: points to ponder
Year: 2014

Change in lung functions in patients with COPD during 6MWT
Source: Annual Congress 2013 –Clinical exercise physiology
Year: 2013

Lung clearance index is increased in patients with COPD
Source: International Congress 2015 – Monitoring and phenotyping COPD
Year: 2015

Heterogeneity inside group D COPD patients: About 827 cases
Source: International Congress 2016 – Biomarkers and phenotypes of COPD
Year: 2016


Gender differences in COPD patients
Source: International Congress 2014 – Clinical presentations
Year: 2014

The effect of Vitamin D deficiency on lung function in current smoker COPD patients
Source: International Congress 2014 – Rationale behind respiratory drug development
Year: 2014

COPD and lung cancer: Prevalence, infradiagnosis, phenotypes and multidimensional characterization
Source: International Congress 2016 – Epidemiology and specific subgroups in lung cancer
Year: 2016


Evaluation of vitamin D levels in COPD and its correlation with disease severity and frequency of exacerbations
Source: International Congress 2014 – Mechanisms of COPD and inhalation injury
Year: 2014


Evolution of COPD phenotypes in time - Czech multicentre research database of severe COPD
Source: International Congress 2016 – Phenotyping and monitoring airway diseases
Year: 2016


The relationship between presence of small airways disease and baseline characteristics of asthma and COPD patients
Source: International Congress 2016 – Monitoring airway diseases with different tools
Year: 2016



Clinical characteristics, pulmonary function, and response to beta2-agonist: Patients with asthma vs. patients with asthma/COPD overlap syndrome
Source: Annual Congress 2013 –Asthma at the bedside
Year: 2013


Differences in the disease phenotype and comorbidities between patients with COPD and alpha-1-antitrypsin deficiency - An analysis of the COSYCONET cohort
Source: International Congress 2016 – Prevalence, prognosis, and risk factors of COPD
Year: 2016

Determinants of severity of dyspnea in COPD
Source: Annual Congress 2013 –COPD mechanisms
Year: 2013


Breathlessness perception in COPD: Relationship with exacerbation frequency
Source: International Congress 2015 – Multidimensional analysis of respiratory problems
Year: 2015


Features of systemic inflammation in patients with stable COPD
Source: International Congress 2014 – COPD: points to ponder
Year: 2014


Lung cancer in patient with chronic obstructive pulmonary disease (comorbidity by smokers-a cumulative effect of exogenic and endogenic factors? Part II)
Source: Annual Congress 2013 –COPD treatment
Year: 2013